Life Sciences

The fundamental real estate challenge for the life sciences company is to ensure the greatest measure of flexibility for its expensive, highly specialized, long-term fixed assets.

The Global Life Sciences Practice offers industry leaders a partner in meeting this challenge. Our professionals have decades of experience covering all sectors—pharmaceutical, biopharmaceutical, biotechnology, and medical devices—and all asset classes—R&D, manufacturing, distribution, and office. With engagements spanning four continents, the Practice helps clients to leverage the global market and effectively maneuver through a fluid landscape in order to improve margins, maximize productivity, and remain competitive in every sector.

Drawing from this broad experience, the Practice’s consultants and transaction specialists add particular value by correlating the metrics of real estate with those of a company’s business goals. This allows our clients greater flexibility to:

Scale-up commercial operations
Attract top scientific talent
Gravitate to emerging therapeutic fields
Migrate to lower cost environments
Shed unneeded obligations
Monetize underutilized assets

Change is a constant on the life sciences horizon. Partner with the Global Life Sciences Practice and experience the confidence afforded by a well-designed real estate platform and the advantages inherent to preparedness.

We offer regional and global experience with global pharmaceutical, biopharmaceutical, biotechnology, and biomedical companies. The Practice also maintains partnerships with organizations dedicated to the advancement of the life sciences, including leading research-based companies, academic institutions, and government agencies.

Actionable Strategies
Operational complexity and long product life cycles make real estate strategy development both challenging and essential for a life sciences company. The Practice develops strategies that seamlessly balance multiple operational and financial considerations while maintaining alignment with a company’s core business objectives. For example, our strategies:

Promote revenue generation while supporting the risk management considerations of research, clinical trials, product-approvals, commercial launches and patent expirations.
Optimize supply chain networks, improve footprint configuration, and facilitate non-core business process deployment while creating significant enterprise value for the client.
Ensure the efficient use of capital in the funding of R&D and manufacturing facilities while remaining sensitive to life-cycle considerations in relation to planning and construction of critical facilities the cost-pressures of location selection.

Global Team
The Global Life Sciences Practice understands the global structure of the industry’s product model and consumer base and operates accordingly. The Practice is driven by a global leadership team—representing the Americas, Europe, and Asia—to ensure that geographically unique challenges are met with geographically appropriate solutions. In each of these regions, the Practice recruits professionals with relevant expertise in established and emerging life sciences markets.

Equally important, the Practice offers flexible strategic models and access to the diverse global resources of Cushman & Wakefield, thereby helping companies to contend with the complex consumer, competitor, and convergence issues that make the life sciences industry fluid and challenging.

Contact Us

Find a contact

View